These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18989794)

  • 1. Study on the spatial architecture of p53, MDM2, and p14ARF containing complexes.
    Savchenko A; Yurchenko M; Snopok B; Kashuba E
    Mol Biotechnol; 2009 Mar; 41(3):270-7. PubMed ID: 18989794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-encoded EBNA-5 forms trimolecular protein complexes with MDM2 and p53 and inhibits the transactivating function of p53.
    Kashuba E; Yurchenko M; Yenamandra SP; Snopok B; Szekely L; Bercovich B; Ciechanover A; Klein G
    Int J Cancer; 2011 Feb; 128(4):817-25. PubMed ID: 20473904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple interacting domains contribute to p14ARF mediated inhibition of MDM2.
    Clark PA; Llanos S; Peters G
    Oncogene; 2002 Jul; 21(29):4498-507. PubMed ID: 12085228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nondenaturing polyacrylamide gel electrophoresis to study the dissociation of the p53·MDM2/X complex by potentially anticancer compounds.
    Sgammato R; Desiderio D; Lamberti A; Raimo G; Novellino E; Carotenuto A; Masullo M
    Electrophoresis; 2015 Dec; 36(24):3101-4. PubMed ID: 26383830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The C terminus of p53 binds the N-terminal domain of MDM2.
    Poyurovsky MV; Katz C; Laptenko O; Beckerman R; Lokshin M; Ahn J; Byeon IJ; Gabizon R; Mattia M; Zupnick A; Brown LM; Friedler A; Prives C
    Nat Struct Mol Biol; 2010 Aug; 17(8):982-9. PubMed ID: 20639885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer.
    Agrawal A; Yang J; Murphy RF; Agrawal DK
    Exp Mol Pathol; 2006 Oct; 81(2):115-22. PubMed ID: 16919268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of p53 C-terminal acetylation by mdm2, p14ARF, and cytoplasmic SirT2.
    van Leeuwen IM; Higgins M; Campbell J; McCarthy AR; Sachweh MC; Navarro AM; Laín S
    Mol Cancer Ther; 2013 Apr; 12(4):471-80. PubMed ID: 23416275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P14ARF promotes accumulation of SUMO-1 conjugated (H)Mdm2.
    Xirodimas DP; Chisholm J; Desterro JM; Lane DP; Hay RT
    FEBS Lett; 2002 Sep; 528(1-3):207-11. PubMed ID: 12297306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between p53-associated proteins and estrogen receptor status in ovarian serous neoplasms.
    Cho EY; Choi YL; Chae SW; Sohn JH; Ahn GH
    Int J Gynecol Cancer; 2006; 16(3):1000-6. PubMed ID: 16803476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time surface plasmon resonance monitoring of site-specific phosphorylation of p53 protein and its interaction with MDM2 protein.
    Wu L; He Y; Hu Y; Lu H; Cao Z; Yi X; Wang J
    Analyst; 2019 Oct; 144(20):6033-6040. PubMed ID: 31502598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SMAR1 forms a ternary complex with p53-MDM2 and negatively regulates p53-mediated transcription.
    Pavithra L; Mukherjee S; Sreenath K; Kar S; Sakaguchi K; Roy S; Chattopadhyay S
    J Mol Biol; 2009 May; 388(4):691-702. PubMed ID: 19303885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of the p14ARF-p53-MDM2 pathway in oral squamous cell carcinoma: MDM2 overexpression is a common event.
    Lim KP; Sharifah H; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2005 Oct; 14(4):963-8. PubMed ID: 16142358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of p14ARF on the levels of ubiquitinated p53 and Mdm2 in vivo.
    Xirodimas D; Saville MK; Edling C; Lane DP; Laín S
    Oncogene; 2001 Aug; 20(36):4972-83. PubMed ID: 11526482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular stress and DNA damage invoke temporally distinct Mdm2, p53 and PML complexes and damage-specific nuclear relocalization.
    Kurki S; Latonen L; Laiho M
    J Cell Sci; 2003 Oct; 116(Pt 19):3917-25. PubMed ID: 12915590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MDM2-p53 interaction.
    Moll UM; Petrenko O
    Mol Cancer Res; 2003 Dec; 1(14):1001-8. PubMed ID: 14707283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Reactive Oxygen and Nitrogen Species Produced by Plasma on Mdm2-p53 Complex.
    Attri P; Kurita H; Koga K; Shiratani M
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The electrostatic surface of MDM2 modulates the specificity of its interaction with phosphorylated and unphosphorylated p53 peptides.
    Brown CJ; Srinivasan D; Jun LH; Coomber D; Verma CS; Lane DP
    Cell Cycle; 2008 Mar; 7(5):608-10. PubMed ID: 18256546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dynamical model on the network of p53-Mdm2 feedback loop regulated by p14/19ARF.
    Liu H; Han YR; Zhan Y; Chen YF; Zhang YH; Yu H; Zhao TJ; Zhuo YZ
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():4235-8. PubMed ID: 18002937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P14ARF deficiency and its correlation with overexpression of p53/MDM2 in sporadic vestibular schwannomas.
    Chen Y; Wang ZY; Wu H
    Eur Arch Otorhinolaryngol; 2015 Sep; 272(9):2227-34. PubMed ID: 24964769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.